Lipid metabolism: inflammatory-immune responses in atherosclerosis
Authors:
- 1 June 2003
- journal article
- bimonthly update
- Published by Wolters Kluwer Health in Current Opinion in Lipidology
- Vol. 14 (3) , 337-339
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- 15-Deoxy-prostaglandin J2 inhibits PDGF-A and -B chain expression in human vascular endothelial cells independent of PPARγBiochemical and Biophysical Research Communications, 2002
- Association of C-Reactive Protein With Carotid Atherosclerosis in Men and Women: The Framingham Heart StudyArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- HMG-CoA reductase inhibition and PPAR-alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cellsClinical Science, 2002
- 15-Deoxy-Δ12,14-prostaglandin J2Journal of Biological Chemistry, 2002
- The Mechanisms of Action of PPARsAnnual Review of Medicine, 2002
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinaseNature, 2000
- The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activationNature, 1998
- A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiationCell, 1995
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγCell, 1995